DE69919705D1 - Diarylselenid-verbindungen und ihre verwendung in menschliche oder tierische medizin wie in kosmetologie - Google Patents

Diarylselenid-verbindungen und ihre verwendung in menschliche oder tierische medizin wie in kosmetologie

Info

Publication number
DE69919705D1
DE69919705D1 DE69919705T DE69919705T DE69919705D1 DE 69919705 D1 DE69919705 D1 DE 69919705D1 DE 69919705 T DE69919705 T DE 69919705T DE 69919705 T DE69919705 T DE 69919705T DE 69919705 D1 DE69919705 D1 DE 69919705D1
Authority
DE
Germany
Prior art keywords
cosmetology
human
animal medicine
diarylselenide
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69919705T
Other languages
English (en)
Other versions
DE69919705T2 (de
Inventor
Jean-Michel Bernardon
Philippe Diaz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9527328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69919705(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Application granted granted Critical
Publication of DE69919705D1 publication Critical patent/DE69919705D1/de
Publication of DE69919705T2 publication Critical patent/DE69919705T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00—Compounds containing selenium
    • C07C391/02—Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
DE69919705T 1998-06-12 1999-06-11 Diarylselenide und ihre Verwendung in der Humanmedizin, Verterinärmedizin oder Kosmetologie Expired - Lifetime DE69919705T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9807439 1998-06-12
FR9807439A FR2779720B1 (fr) 1998-06-12 1998-06-12 Nouveaux composes diarylselenures et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie
PCT/FR1999/001389 WO1999065872A1 (fr) 1998-06-12 1999-06-11 Composes diarylselenures et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie

Publications (2)

Publication Number Publication Date
DE69919705D1 true DE69919705D1 (de) 2004-09-30
DE69919705T2 DE69919705T2 (de) 2005-09-15

Family

ID=9527328

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69919705T Expired - Lifetime DE69919705T2 (de) 1998-06-12 1999-06-11 Diarylselenide und ihre Verwendung in der Humanmedizin, Verterinärmedizin oder Kosmetologie

Country Status (19)

Country Link
US (2) US6992094B1 (de)
EP (1) EP1086080B1 (de)
JP (1) JP3566210B2 (de)
KR (1) KR100429045B1 (de)
CN (1) CN1267418C (de)
AR (1) AR015311A1 (de)
AT (1) ATE274493T1 (de)
AU (1) AU753187B2 (de)
BR (1) BR9911833A (de)
CA (1) CA2334843C (de)
DE (1) DE69919705T2 (de)
DK (1) DK1086080T3 (de)
ES (1) ES2228048T3 (de)
FR (1) FR2779720B1 (de)
IL (1) IL140076A0 (de)
NO (1) NO20006337L (de)
PT (1) PT1086080E (de)
WO (1) WO1999065872A1 (de)
ZA (1) ZA200006518B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT412703B (de) 2001-12-04 2005-06-27 Vis Vitalis Lizenz & Handels Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
JP2006511444A (ja) * 2002-06-04 2006-04-06 ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ Ｒａｒ受容体の阻害剤であるリガンド
FR2840300B1 (fr) * 2002-06-04 2004-07-16 Galderma Res & Dev NOUVEAUX LIGANDS INHIBITEURS DES RECEPTEURS RARs, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION EN MEDECINE HUMAINE AINSI QU'EN COSMETIQUE
FR2847255B1 (fr) * 2002-11-18 2006-11-17 Galderma Res & Dev Nouveaux ligands antagonistes des recepteurs rars, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
CA2505286C (en) 2002-11-18 2012-02-07 Galderma Research & Development, S.N.C. Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2931661B1 (fr) 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.
AT511159A1 (de) 2011-02-16 2012-09-15 Selo Medical Gmbh Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
CN103086935B (zh) * 2011-10-28 2015-05-20 沈阳药科大学 二苯硒醚、二苯硒亚砜、二苯硒砜类化合物及其用途
EP3262942A1 (de) * 2016-06-27 2018-01-03 Evonik Degussa GmbH Selenodiaryle zur anwendung als mikrobizid sowie als arzneimittel

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0170105B1 (de) 1984-07-07 1990-10-17 Koichi Prof. Dr. Shudo Benzoesäurederivate
FR2601670B1 (fr) * 1986-07-17 1988-10-07 Cird Nouveaux derives bicycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
FR2676439B1 (fr) 1991-05-13 1994-10-28 Cird Galderma Nouveaux composes bi-aromatiques derives d'un motif salicylique, leur procede de preparation et leur utilisation en medecine humaine et veterinaire ainsi qu'en cosmetique.
WO1993021146A1 (en) * 1992-04-22 1993-10-28 Ligand Pharmaceuticals Incorporated Compounds having selectivity for retinoid x receptors
EP0671005A1 (de) * 1992-11-25 1995-09-13 La Jolla Cancer Research Foundation Rxr-homodimerbildung und verbrückte bizyklische aromatische verbindungen sowie ihre verwendung bei der modulation der genexpression
DK0678086T3 (da) * 1993-01-11 2000-04-17 Ligand Pharm Inc Forbindelser med selektivitet over for retinoid-X-receptorer
FR2713635B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2719043B1 (fr) 1994-04-26 1996-05-31 Cird Galderma Nouveaux composés bicycliques-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2722985B1 (fr) * 1994-07-27 1996-09-13 Cird Galderma Nouvelles compositions a base d'un melange synergetique entre au moins un ligand specifique des rxrs et au moins un ligand specifique de rar-x ou de vdr, et leurs utilisations
AU7598596A (en) * 1995-11-01 1997-05-22 Allergan, Inc. Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
FR2755965B1 (fr) * 1996-11-19 1998-12-18 Cird Galderma Composes biaromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Also Published As

Publication number Publication date
JP3566210B2 (ja) 2004-09-15
US6992094B1 (en) 2006-01-31
CA2334843A1 (fr) 1999-12-23
CN1267418C (zh) 2006-08-02
KR20010052781A (ko) 2001-06-25
FR2779720A1 (fr) 1999-12-17
NO20006337D0 (no) 2000-12-12
DE69919705T2 (de) 2005-09-15
EP1086080A1 (de) 2001-03-28
AU4049199A (en) 2000-01-05
BR9911833A (pt) 2001-09-25
DK1086080T3 (da) 2005-01-17
JP2002518371A (ja) 2002-06-25
ES2228048T3 (es) 2005-04-01
EP1086080B1 (de) 2004-08-25
AR015311A1 (es) 2001-04-18
US20060014803A1 (en) 2006-01-19
KR100429045B1 (ko) 2004-04-29
ATE274493T1 (de) 2004-09-15
WO1999065872A1 (fr) 1999-12-23
CN1305458A (zh) 2001-07-25
IL140076A0 (en) 2002-02-10
FR2779720B1 (fr) 2002-08-16
PT1086080E (pt) 2004-12-31
NO20006337L (no) 2001-02-12
AU753187B2 (en) 2002-10-10
ZA200006518B (en) 2001-07-30
CA2334843C (fr) 2006-11-21

Similar Documents

Publication Publication Date Title
DE69804793D1 (de) Klinisches und/oder chirurgisches trainingsgerät
DE69911378D1 (de) Fluorierte ionomere und verwendung davon
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69817022D1 (de) In lebenden Gewebe Implantierbare hintereinandergeschaltete Sensoren und Stimulatoren
NO20034430L (no) Tiohydantoiner og anvendelse derav for behandling av diatbetes
EE04566B1 (et) Epotilooni derivaadid ja nende kasutamine meditsiinis
IL160917A0 (en) Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
BR9708882A (pt) Triazolil mercaptidas e sua ulitização como microbicidas
DE69719603D1 (de) Kosmetisches Haarwaschmittel und dessen Verwendung
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
ID26999A (id) Komposisi perawatan kulit
NO975439D0 (no) Ketonderivater og medisinsk anvendelse derav
AU2003280918A8 (en) Rabbit skin comprising biological active substance and its use
ATE225764T1 (de) Bicyclische aromatische verbindungen und ihre anwendung in der menschen- und tierheilkunde sowie in der kosmetikkunde
DE69919705D1 (de) Diarylselenid-verbindungen und ihre verwendung in menschliche oder tierische medizin wie in kosmetologie
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
ATE211469T1 (de) Benzopyrans und deren verwendung als therapeutische mittel
DE50008549D1 (de) Triazolotriazinone und ihre verwendung
DE69822276D1 (de) Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen
DE69812256D1 (de) 7-propyl-benzodiosepin-3-one und dessen Verwendung in Parfümerie
ID25431A (id) Aplikator dengan tampon kesehatan
DE69528261D1 (de) Benzopyrane und deren verwendung als therapeutische mittel
DE69808667T2 (de) Haar- und/oder körperpflegemittel für menschen und tiere
DE805821T1 (de) MENSCHLICHES HERZ-CNBr TROPONIN I-ISOFORM UND DESSEN VERWENDUNG
NO20010044L (no) Anvendelse av texafyriner i makrofag-medierte sykdommer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: GALDERMA RESEARCH & DEVELOPMENT, BIOT, FR